Visiongain publishes Pharmaceutical Contract Manufacturing Market 2020-2030 report
LONDON, Aug. 31, 2020 /PRNewswire/ -- Pharmaceutical Contract Manufacturing-our new study reveals trends, R&D progress, and predicted revenues
Where is the Pharmaceutical Contract Manufacturing market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg
Discover how to stay ahead
Our 543 page report provides 700+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Pharmaceutical Contract Manufacturing Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
-- In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
-- You find original analyses, with business outlooks and developments.
-- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
This Visiongain report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
To request sample pages from this report please email contactus@visiongain.com or refer to our website: https://www.visiongain.com/report/pharma-contract-manufacturing-market-2020-2030/#download_sampe_div
Discover sales predictions for the world market and submarkets
Product Category
-- Pharmaceutical Product Manufacturing
-- Biological Product Manufacturing
Drug Type
-- API Manufacturing
-- FDF Manufacturing
API
-- Small Molecule
-- Large Molecule
-- High Potency API (HPAPI)
FDF
-- Solid Dose Formulation
-- Liquid Dose Formulation
-- Injectable Dose Formulation
-- Other FDFs
By End-User
-- Big Pharma
-- Small & Mid-size Pharma
-- Generic Pharmaceutical Companies
-- Other End-Users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
-- North America
- U.S.
- Canada
-- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
-- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
-- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
-- Middle East and Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
- Egypt
- Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Pharmaceutical Contract Manufacturing Market, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth
Overall world revenue for Pharmaceutical Contract Manufacturing Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Pharmaceutical Contract Manufacturing Market report helps you
In summary, our 543 page report provides you with the following knowledge:
-- Revenue forecasts to 2030 for Pharmaceutical Contract Manufacturing Market, with forecasts for Product Category, Drug Type, API, FDF, and End User, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
-- Revenue forecasts to 2030 for 5 regional and 16 key national markets - See forecasts for the Pharmaceutical Contract Manufacturing market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
-- Prospects for established firms and those seeking to enter the market- including company profiles for 13 of the major companies involved in the Pharmaceutical Contract Manufacturing Market. Some of the company's profiled in this report include Catalent Inc., Lonza Group AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Mylan NV, AbbVie Inc., Piramal Enterprises Ltd, Consort Medical plc, Baxter International Inc, Alkermes Plc, Bayer AG, GlaxoSmithKline plc, and NIPRO CORPORATION.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To request a report overview of this report please email contactus@visiongain.com or refer to our website: https://www.visiongain.com/report/pharma-contract-manufacturing-market-2020-2030/
Did you know that we also offer a report add-on service? Email contactus@visiongain.com to discuss any customized research needs you may have.
Companies covered in the report include:
Companies Profiled in the Report
AbbVie Inc
Alkermes Plc
Baxter International Inc
Bayer AG
Catalent Inc.
Consort Medical plc
Evonik Industries AG
GlaxoSmithKline plc
Lonza Group AG
Mylan NV
NIPRO CORPORATION
Piramal Enterprises Ltd
Teva Pharmaceutical Industries Ltd
List of Companies Mentioned in the Report
AbbVie
Actavis
ADC Biotechnology
Aegerion Pharmaceuticals
Aenova Group
Aesica Pharma
Agensys
Agila Specialties
Ajinomoto Althea Inc
Alexion Pharmaceuticals
Almac Group
Althea Technologies
AMRI (Albany Molecular Research Inc)
API Corporation (APIC)
Aspen Pharmacare
Astellas
AstraZeneca
Banner Life Sciences
Banner Pharmacaps
Baring Private Equity Asia
Bausch & Lomb
Bayer Healthcare
Ben Venue Laboratories
Bend Research
Biogen Idec
BioIndustry Association (BIA)
Biotest
Blackstone Group
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence
Bristol-Myers Squibb Company
Bushu Pharmaceuticals
Cambrex
Cambridge Major Laboratories
Catalent Pharma Solutions
Cedarburg Hauser
Cell Therapy Catapult
Celldex Therapeutics
Celltrion
Cenexi
Chemisch-Pharmazeutisches Laboratorium Ravensburg
Chemtrix
China FDA (CFDA)
Cipla
Cook Pharmica
CordenPharma
CTC Bio
Daito Pharmaceutical
Delpharm
Dishman Pharmaceuticals
DPx Fine Chemicals
DPx Holdings B.V.
Dr. Reddy's Laboratories
DSP (DSM Sinochem Pharmaceuticals)
Eisai
Eli Lilly
Esteve Quimica
Euticals
Evonik Degussa
Famar
Fareva
FUJIFILM Diosynth Biotechnologies,
G-CON
Gallus Biopharmaceutical, LLC.
GEA Pharma-Systems
Genentech
GlaxoSmithKline (GSK)
Granules India
Haupt Pharma
Hexal
Hospira
Hospira One2One
ImmunoGen
Immunomedics
Indian Pharmaceutical Alliance
Innovent Biologics
IRIX Pharmaceuticals
Janssen
JK Pharmaceutical
Johnson & Johnson
Knowledge Transfer Network (KTN)
Lonza
Lupin
Marinopoulos Group
Matrix Laboratories
Medice
Medichem
Merck & Co.
Micron Technologies
Millennium
Mitsui & Co
Momenta Pharmaceuticals
Mylan
Neuland Laboratories
NICE Insight
NPS Pharmaceuticals
Nycomed
Orchid Chemicals & Pharmaceuticals
Oxford Biomedica
Patheon
Patheon Biologics
Pfizer
Pharmapak Technologies
Piramal Pharma Solutions
Progenics
Quintiles
Recepta Biopharma
Recipharm
Redwood Bioscience
Rentschler Biotechnologie
Roche
Royal DSM
SAFC
SafeBridge
Samsung Bioepis
Samsung BioLogics
Sandoz
Sanofi
Seattle Genetics
Shandong Xinhua
ShangPharma
Shire
Siegfried AG
Sigmar Italia
SMS Pharmaceuticals
Solvias AG
Speedel
Stada
Stem CentRx
Stevenage Bioscience Catalyst
Takeda
Temmler Group
Teva API
Thermo Fisher Scientific
UMN Pharma
UNIGEN
Valeant Pharmaceuticals
Valerion Therapeutics, LLC.
Vetter Pharma-Fertigung GmbH
Vivante GMP Solutions
West Pharmaceutical Services
WuXi PharmaTech
Zhangjiang Biotech & Pharmaceutical Base Company
Zhejiang Jiang Yuan Tang Biotechnology
List of Organizations Mentioned in the Report
Agência Nacional de Vigilância Sanitária (ANVISA)
Asociación Española de Fabricantes de Productos de Química Fina (AFAQUIM)
Associação Brasileira da Indústria Farmoquímica e de Insumos Farmacêuticos (ABIQUIFI)
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
European Commission
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
Indian Drug Manufacturer's Association (IDMA)
International Society of Pharmaceutical Engineering (IPSE)
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer's Association (KPMA)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
Pharmaceutical and Medical Devices Agency (PMDA)
World Health Organization (WHO)
To see a report overview please e-mail contactus@visiongain.com
RELATED REPORTS:
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030
Vaccine Contract Manufacturing Market Forecast 2020-2030
Biopharmaceuticals Contract Manufacturing Market Report 2020-2030
Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030
Top 55 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2020
View original content:http://www.prnewswire.com/news-releases/visiongain-publishes-pharmaceutical-contract-manufacturing-market-2020-2030-report-301120379.html
SOURCE Visiongain
